BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 35265228)

  • 1. Metabolic phenotyping of tear fluid as a prognostic tool for personalised medicine exemplified by T2DM patients.
    Brunmair J; Bileck A; Schmidl D; Hagn G; Meier-Menches SM; Hommer N; Schlatter A; Gerner C; Garhöfer G
    EPMA J; 2022 Mar; 13(1):107-123. PubMed ID: 35265228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine.
    Zhan X; Li J; Guo Y; Golubnitschaja O
    EPMA J; 2021 Dec; 12(4):449-475. PubMed ID: 34876936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short communication: unique metabolic signature of proliferative retinopathy in the tear fluid of diabetic patients with comorbidities - preliminary data for PPPM validation.
    Kropp M; De Clerck E; Vo TKS; Thumann G; Costigliola V; Golubnitschaja O
    EPMA J; 2023 Mar; 14(1):43-51. PubMed ID: 36845280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabo-tip: a metabolomics platform for lifestyle monitoring supporting the development of novel strategies in predictive, preventive and personalised medicine.
    Brunmair J; Bileck A; Stimpfl T; Raible F; Del Favero G; Meier-Menches SM; Gerner C
    EPMA J; 2021 Jun; 12(2):141-153. PubMed ID: 34188726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.
    Hagan S; Martin E; Enríquez-de-Salamanca A
    EPMA J; 2016; 7(1):15. PubMed ID: 27413414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single unit filter-aided method for fast proteomic analysis of tear fluid.
    Aass C; Norheim I; Eriksen EF; Thorsby PM; Pepaj M
    Anal Biochem; 2015 Jul; 480():1-5. PubMed ID: 25862084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of Oligoclonal IgG Bands in Tear Fluid of Multiple Sclerosis Patients.
    Hümmert MW; Wurster U; Bönig L; Schwenkenbecher P; Sühs KW; Alvermann S; Gingele S; Skripuletz T; Stangel M
    Front Immunol; 2019; 10():1110. PubMed ID: 31164889
    [No Abstract]   [Full Text] [Related]  

  • 8. The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation.
    Golubnitschaja O; Polivka J; Potuznik P; Pesta M; Stetkarova I; Mazurakova A; Lackova L; Kubatka P; Kropp M; Thumann G; Erb C; Fröhlich H; Wang W; Baban B; Kapalla M; Shapira N; Richter K; Karabatsiakis A; Smokovski I; Schmeel LC; Gkika E; Paul F; Parini P; Polivka J
    EPMA J; 2024 Mar; 15(1):1-23. PubMed ID: 38463624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which are the best parameters to obtain proteins and malondialdehyde from a tear sample?
    Calvo R; López-Malo D; Penadés M; Romero FJ; Peris-Martínez C
    Exp Eye Res; 2019 Nov; 188():107656. PubMed ID: 31028749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid.
    Cicalini I; Rossi C; Pieragostino D; Agnifili L; Mastropasqua L; di Ioia M; De Luca G; Onofrj M; Federici L; Del Boccio P
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of tear fluid reveals disease-specific patterns in patients with Parkinson's disease - A pilot study.
    Boerger M; Funke S; Leha A; Roser AE; Wuestemann AK; Maass F; Bähr M; Grus F; Lingor P
    Parkinsonism Relat Disord; 2019 Jun; 63():3-9. PubMed ID: 30876839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of Inter- and Intra-Day Variability of Tear Fluid Regarding Flow Rate, Protein Concentration as well as Protein Composition.
    Guntermann A; Fatoba O; Kronenberg M; Reinehr S; Grotegut P; Schargus M; Tsai T; Ivanova S; Serschnitzki B; Kumowski N; Maier C; Marcus K; Dick HB; Joachim SC; May C
    Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):13. PubMed ID: 37815507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dry sweat as sample for metabolomics analysis.
    Delgado-Povedano MM; Castillo-Peinado LS; Calderón-Santiago M; Luque de Castro MD; Priego-Capote F
    Talanta; 2020 Feb; 208():120428. PubMed ID: 31816748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tear proteomic analysis of patients with type 2 diabetes and dry eye syndrome by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry.
    Li B; Sheng M; Xie L; Liu F; Yan G; Wang W; Lin A; Zhao F; Chen Y
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):177-86. PubMed ID: 24282230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient acceptability of tear collection in the primary healthcare setting.
    Quah JH; Tong L; Barbier S
    Optom Vis Sci; 2014 Apr; 91(4):452-8. PubMed ID: 24492756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Targeted Analysis of Metabolites and Proteins in Tear Fluid With Regard to Clinical Applications.
    Dammeier S; Martus P; Klose F; Seid M; Bosch D; D'Alvise J; Ziemssen F; Dimopoulos S; Ueffing M
    Transl Vis Sci Technol; 2018 Nov; 7(6):22. PubMed ID: 30564511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putative Biomarkers in Tears for Diabetic Retinopathy Diagnosis.
    Amorim M; Martins B; Caramelo F; Gonçalves C; Trindade G; Simão J; Barreto P; Marques I; Leal EC; Carvalho E; Reis F; Ribeiro-Rodrigues T; Girão H; Rodrigues-Santos P; Farinha C; Ambrósio AF; Silva R; Fernandes R
    Front Med (Lausanne); 2022; 9():873483. PubMed ID: 35692536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine.
    Bajinka O; Ouedraogo SY; Golubnitschaja O; Li N; Zhan X
    EPMA J; 2024 Jun; 15(2):289-319. PubMed ID: 38841622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of IgG N-glycomics with prevalent and incident type 2 diabetes mellitus from the paradigm of predictive, preventive, and personalized medicine standpoint.
    Meng X; Wang F; Gao X; Wang B; Xu X; Wang Y; Wang W; Zeng Q
    EPMA J; 2023 Mar; 14(1):1-20. PubMed ID: 36866157
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.